Similarities and differences of tokishakuyakusan and estrogen

Journal of Traditional Medicines

Volumn 26, Issue 42496, 2009, Pages 195-200

  Chung, Mi Hwa ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

estrogen; PACAP; StAR; Tokishakuyakusan

Indexed keywords

EID: 84856652892     PISSN: 18801447     EISSN: 18813747     Source Type: Journal    
DOI: 10.11339/jtm.26.195     Document Type: Article

References (33)

1. Usuki, S., Nakauchi, T., Higa, S. and Someya, K.: The improvement of luteal insufficiency in fecund women by tokishakuyakusan treatment. Am. J. Chin. Med., 30, 327-338, 2002.
2. Hagino, N.: Kampo medicine and neuroendocrine -From here to molecular biology. J. Trad. Med., 13, 105-117, 1996.
3. Usuki, S.: Effects of hachimijiogan, tokishakuyakusan and keishibukuryogan on estrogen and progesterone secretions by rat preovulatory follicles. Am. J. Chin. Med., 14, 161-170, 1986.
4. Usuki, S.: Effects of hachimijiogan, tokishakuyakusan and keishibukuryogan on progesterone secretions by corpus luteum. Am. J. Chin. Med., 15, 109-115, 1987.
5. Usuki, S.: Effects of herbal components of tokishakuyakusan on progesterone secretion by corpus luteum in vitro. Am. J. Chin. Med., 19, 57-60, 1991.
6. Usuki, S.: Tokishakuyakusan stimulates progesterone and estradiol-17 beta production by rat granulosa cells and progesterone, testosterone and estradiol-17 beta by the residual portion of the follicle in vitro. Am. J. Chin. Med., 19, 155-161, 1991.
7. Usuki, S.: The direct luteotropic effect of tokishakuyakusan in rats. Am. J. Chin. Med., 19, 163-169, 1991.
8. Usuki, S.: Tokishakuyakusan stimulates cyclic adenosine 3′,5′-monophosphate accumulation and progestin production by corpora lutea. Am. J. Chin. Med., 16, 21-28, 1988.
9. Usuki, S.: Blended effects of herbal components of tokishakuyakusan on rat corpus luteum function in vivo. Am. J. Chin. Med., 16, 107-116, 1988.
10. Akase, T., Hihara, E., Shimada, T., Kojima, K., Akase, T., Tashiro, S. and Aburada, M.: Efficacy of Tokishakuyakusan on the anemia in the iron-deficient pregnant rats. Biol. Pharm. Bull., 30, 1523-1528, 2007.
11. Nasu, Y., Iwashita, M., Saito, M., Fushiya, S. and Nakahata, N.: Inhibitory effects of Atractylodis Lanceae Rhizoma and Poria on collagen- or thromboxane A2-induced aggregation in rabbit platelets. Biol. Pharm. Bull., 32, 856-860, 2009.
12. Goto, H., Satoh, N., Hayashi, Y., Hikiami, H., Nagata, Y., Obi, R. and Shimada, Y.: A Chinese herbal medicine, Tokishakuyakusan, reduces the worsening of impairments and independence after stroke:A 1-year randomized, controlled trial. eCAM, Advance Access published on March 30, 2009.
13. Chung, M. H., Suzuki, S., Nishihara, T. and Hattori, M.: Estrogenic effects of a Kampo formula, Tokishakuyakusan, in parous ovariectomized rats. Biol. Pharm. Bull., 31, 1145-1149, 2008.
14. Xie, L. H., Ahn, E. M., Akao, T., Abdel-Hafez, A. A., Nakamura, N. and Hattori, M.: Transformation of arctiin to estrogenic and antiestrogenic substances by human intestinal bacteria. Chem. Pharm. Bull., 51, 378-384, 2003.
15. Ahn, E. M., Akao, T., Nakamura, N., Komatsu, K., Nishihara, T. and Hattori, M.: Screening of medicinal plant extracts for estrogenic activity in combination with a glycosidase treatment. J. Trad. Med., 21, 81-86, 2004.
16. Clark, B. J., Wells, J., King, S. R. and Stocco, D. M.: The purification, cloning, and expression of a novel luteinizing hormone-induced mitochondrial protein in MA-10 mouse Leydig tumor cells. Characterization of the steroidogenic acute regulatory protein (StAR). J. Biol. Chem., 269, 28314-28322, 1994.
17. Simpson, E. R. and Waterman, M. R.: Regulation of the synthesis of steroidogenic enzymes in adrenal cortical cells by ACTH. Annu. Rev. Physiol., 50, 427-440, 1988.
18. Apostolakis, E. M., Lanz, R. and O'Malley, B. W.: Pituitary adenylate cyclase-activating peptide: a pivotal modulator of steroid-induced reproductive behavior in female rodents. Mol. Endocrinol., 18, 173-183, 2004.
19. Chung, M. H., Nakamura, N., Tohda, M. and Hattori, M.: Effects of Tokishakuyakusan on hypothalamic pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP type I receptor (PAC1) expression in hypophysectomized and ovariectomized rats. J. Trad. Med., 24, 24-30, 2007.
20. Schwartz, N. B.: Neuroendocrine regulation of reproductive cyclicity. Neuroendocrinology in Physiology and Medicine, (Ed. by Conn, P. M. and Freeman, M. E.), Humana Press, New York, pp.135-146, 2000.
21. Tena-Sempere, M. and Huhtaniemi, I.: Gonadotropins and gonadotropin receptors. Reproductive Medicine-Molecular, Cellular and Genetic Fundamentals, (Ed, by Fauser, B. C. J. M.), Parthenon, New York, pp.225-244, 2003.
22. Chung, M. H., Tohda, M. and Hattori, M.: Effects of Tokishakuyakusan on the ovary in hypophysectomized rats. J. Trad. Med., 24, 31-38, 2007.
23. Burger, H.: Hormone replacement therapy in the post-Women's Health Initiative era. Report a meeting held in Funchal, Madeira, February 24-25, 2003. Climacteric, 6, 11-36, 2003.
24. Derry, P. S.: Hormones, menopause, and heart disease: making sense of the Women's Health Initiative. Womens Health Issues, 14, 212-219, 2004.
25. Derry, P. S.: Update on hormones, menopause, and heart disease: evaluating professional responses to the Women's Health Initiative. Health Care Women Int., 29, 720-737, 2008.
26. Inoue, H., Kawauchi, H., Suzuki-Hotta, M., Ogata, T., Tachibana, K., Takeuchi, H., Mikamo, H., Kitamura, K., Ohta, H., Yoshikawa, H., Rin, H., Susumu, N., Aoki, D., Shimizu, Y., Matsui, H., Fukutomi, T. and Matsumura, J.: Medical Disease: An Illustrated Reference Guide Genecology. (Ed. by Ueda, M., Osuga, J.), Medic Media, Tokyo, pp.122-123, 2006.
27. Ioachin, E.: Immunohistochemical tumour markers in endometrial carcinoma. Eur. J. Gynaecol. Oncol. 26, 363-371, 2005.
28. Larsen, P. R., Kronenberg, H. M., Melmed, S. and Polonsky, K. S.: Williams Textbook of Endocrinology. (Ed. by Catherine, C., Faith, V.), Saunders (Elsevier), USA, pp. 644-645, 2003.
29. Weisz, A. and Rosales, R.: Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor. Nucleic Acids Res., 18, 5097-5106, 1990.
30. Colotta, F., Polentarutti, N., Sironi, M. and Mantovani, A.: Expression and involvement of c-fos and c-jun protooncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell lines. J. Biol. Chem., 267, 18278-18283, 1992.
31. Niwa, K., Murase, T., Furui, T., Morishita, S., Mori, H., Tanaka, T., Mori, H. and Tamaya, T.: Enhancing effects of estrogens on endometrial carcinogenesis initiated by N-methyl-N-nitrosourea in ICR mice. Jpn. J. Cancer Res., 84, 951-955, 1993.
32. Morishita, S., Niwa, K., Ichigo, S., Hori, M., Murase, T., Fujimoto, J. and Tamaya, T.: Overexpressions of c-fos/jun mRNA and their oncoproteins (Fos/Jun) in the mouse uterus treated with three natural estrogens. Cancer Lett., 97, 225-231, 1995.
33. Niwa, K., Morishita, S., Hashimoto, M., Itoh, T., Yokoyama, Y., Mori, H. and Tamaya, T.: Effects of tamoxifen on endometrial carcinogenesis in mice. Jpn. J. Cancer Res., 89, 502-509, 1998.